Shares of ACAD are surging this morning. Here's why:
http://www.marketwatch.com/story/acadia-announces-pimavanserin-meets-primary-and-key-secondary-endpoints-in-pivotal-phase-iii-parkinsons-disease-psychosis-trial-2012-11-27
Tuesday, November 27, 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment